Clinical Spectrum of TH/TO and NOR90 Autoantibodies in Systemic Sclerosis
DOI:
https://doi.org/10.24950/O/326/20/2/2021Keywords:
Antibodies, Scleroderma, Systemic, Signs and SymptomsAbstract
Introduction: Systemic sclerosis is an autoimmune disease with a large spectrum of clinical manifestations. Autoantibodies could indicate symptoms, diagnostics and establish a more appropriate treatment. The relevance of searching Th/To and NOR90 is still unknown. We aim to evaluate major manifestations and disease associations of Th/To and NOR90 autoantibodies.
Material and Methods: Observational retrospective single- centre study, including all patients with Th/To or NOR90 autoantibodies followed in autoimmune consultation from 2018 to 2020. Absence of specific clinical information excluded patients. Demographic, clinical and diagnostical data were analysed.
Results: In this study, female gender was the most prevalent. Cutaneous, articular, cardiopulmonary and gastrointestinal involvements were present in both autoantibodies’ groups, with no renal manifestations. In 40% of both groups, systemic sclerosis diagnosis was established. No other concomitant autoantibodies were documented in 53% and 50% of anti-Th/To and anti-NOR90, respectively.
Discussion and Conclusion: This study verified similar involvement in both groups with frequent skin and articular symptoms, more cardiopulmonary involvement in anti-Th/To group and more gastrointestinal association in anti-NOR90. Although, in this study, these autoantibodies were commonly related to systemic sclerosis, in approximately half of cases they were isolated with no other concomitant systemic sclerosis’ autoantibodies, enhancing the importance of their active research when this disease is suspected.
Downloads
References
Andrade L, Leser P. Auto-Anticorpos na Esclerose Sistêmica. Rev Bras Reumatol. 2004; 3:215-23.
Denton C. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med. 2016; 1:55-60.
Hughes M, Herrick AL. Systemic Sclerosis. Brit J Hosp Med. 2019; 9:530-6.
Ceribelli A, Isailovic N, Santis M, Generali E, Gorlino C, Palermo B, et al. Clinical significance of rare serum autoantibodies in rheumatic diseases: a systematic literature review. J Lab Precis Med. 2018;3:89.
Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear Antibodies in Systemic Sclerosis: an Update. Clin Rev Allerg Immunol. 2020; 58:40-51.
Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, et al. Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma. Rheumatology. 2001;40:683-6.
Ceribelli A, Cavazzana I, Franceschini F, Airò P, Tincani A, Cattaneo R, et al. Prevalence of auto-antibodies associated to pulmonary arterial hypertension in scleroderma – A review. J Rheumatol. 2010; 37:2071-75.
Dagher J, Scheer U, Voit R, Grummt I, Lonzetti L, Raymond Y, et al. J Rheumatol. 2002;29;1543-7
Nunes J, Cunha A, Meirinhos T, Nunes A, Araújo P, Godinho A, et al. Anti-Th/To Are Common Antinucleolar Autoantibodies in Italian Patients with Scleroderma. J Rheumatol. 2010; 37:2071-75.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna